Clinical trial

Safety and Effectiveness Study of Duloxetine HCl in Women of Different…

NCT00190905 · Eli Lilly and Company, Industry · Completed

Key facts

NCT number NCT00190905
Title Safety and Effectiveness Study of Duloxetine HCl in Women of Different Backgrounds With Stress Urinary Incontinence Who May Also Have Other Various Medical Conditions.
Official title Study of Duloxetine HCl in Women of Different Demographic Characteristics and Co-Morbidities With Stress Urinary Incontinence: Evaluation of Efficacy and Safety
Lead sponsor Eli Lilly and Company, Industry
Collaborators Boehringer Ingelheim Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Stress Urinary Incontinence
Intervention type Drug
Interventions duloxetine HCl
Enrollment 4,000
Start date Feb 1, 2004
Completion Jul 1, 2005
First posted Sep 19, 2005
Last update posted Jul 25, 2006
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies